Entrada Therapeutics (TRDA) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.06
-0.7
-0.33
0.03

Details

Expected EPS
-0.94
Actual EPS
-1.06
Surprise EPS
-0.12
Surprise Percent
+12.77%

Description

Entrada Therapeutics (TRDA) has reported earnings of -1.06 per share for Q4 2025.

0 Comments

Share your thoughts